J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campos, E.
Right arrow Articles by Havel, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campos, E.
Right arrow Articles by Havel, R. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 43, 365-374, March 2002
Copyright © 2002 by Lipid Research, Inc.

Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma

Elisa Camposa, Leila Kotitea, Patricia Blanchec, Yasushi Mitsugia, Philip H. Frostb, Umesh Masharanib, Ronald M. Kraussc, and Richard J. Havela
a Cardiovascular Research Institute, University of California San Francisco, 505 Parnassus Avenue, Rm L-1337, San Francisco, CA
b Department of Medicine, University of California San Francisco, 505 Parnassus Avenue, Rm L-1337, San Francisco, CA
c Lawrence Berkeley Laboratory, University of California Berkeley, Berkeley, CA

Correspondence to: Richard J. Havel, To whom correspondence should be addressed., havelr{at}itsa.ucsf.edu (E-mail)

An immunoassay procedure that quantifies remnant-like particle (RLP) cholesterol in human blood plasma has shown considerable promise as a clinically applicable risk marker for atherosclerotic disease. The lipoproteins included in this assay include not only certain TG-rich lipoproteins [all particles containing apolipoprotein B-48 (apoB-48) and a fraction of those containing apoB-100] but also a very small proportion of plasma cholesterol-rich lipoproteins. The TG-rich lipoprotein component of RLP has been partially characterized, but relatively little is known about the component cholesterol-rich lipoproteins. We have further characterized the properties of the TG-rich component that is included in RLP in which about 25% of the particles contain apoB-48 and the remainder apoB-100. We show that the cholesterol-rich component is comprised mainly of ß-migrating LDLs that contain predominantly apoB-100. ApoE found in the LDL fraction of RLP resides on pre-ß lipoproteins that lack apoA-I as well as apoB. The TG-rich component of RLP is responsible for increased RLP-cholesterol concentrations associated with hypertriglyceridemia. By contrast, the cholesterol-rich component is a major contributor to plasma RLP-cholesterol in individuals with low plasma TG.

Our results suggest that particle heterogeneity in the RLP fraction is likely to affect the ability of RLP-cholesterol concentration to predict atherosclerotic risk. RLP-cholesterol concentrations in individuals with low plasma TG may not have the same clinical significance as they do in those with hypertriglyceridemia. — Campos, E., L. Kotite, P. Blanche, Y. Mitsugi, P. H. Frost, U. Masharani, R. M. Krauss, and R. J. Havel. Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma. J. Lipid Res. 2002. 43: 365–374.

Supplementary key words: apolipoproteins, lipoprotein heterogeneity, lipoprotein phenotypes, chromatography, immunoaffinity, diabetes mellitus


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
C.-Q. Lai, S. Demissie, L. A. Cupples, Y. Zhu, X. Adiconis, L. D. Parnell, D. Corella, and J. M. Ordovas
Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study
J. Lipid Res., November 1, 2004; 45(11): 2096 - 2105.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. A. Brinton, M. N. Nanjee, and P. N. Hopkins
Triglyceride-rich lipoprotein remnant levels and metabolism: Time to adopt these orphan risk factors?
J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2233 - 2235.
[Full Text] [PDF]


Home page
CirculationHome page
T.B. Twickler, G.M. Dallinga-Thie, J.S. Cohn, and M.J. Chapman
Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype
Circulation, April 27, 2004; 109(16): 1918 - 1925.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
I. Staprans, X.-M. Pan, J. H. Rapp, and K. R. Feingold
Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum
J. Lipid Res., April 1, 2003; 44(4): 705 - 715.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Kovar and R. J. Havel
Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia
J. Lipid Res., July 1, 2002; 43(7): 1026 - 1034.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.